Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan. (Q51030955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

author

Evelyne Jacqz-Aigrain

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Ute Hofmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Christian Funck-Brentano

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

author name string

Kévorkian JP

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Michel C

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Kroemer HK

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Peraldi MN

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Eichelbaum M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Jaillon P

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

English

0 references

publication date

1 May 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

583-592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

Prediction of creatinine clearance from plasma creatinine: comparison of five formulae

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

The influence of enzyme induction on polymorphic sparteine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Partial metabolic clearances as determinants of the oral bioavailability of propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Phenformin-induced lacticacidosis associated with impaired debrisoquine hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Drug metabolism in extrahepatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Genetic polymorphism of S-mephenytoin hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Pharmacogenetics of dextromethorphan O-demethylation in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Phenotypic differences in dextromethorphan metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Salivary analysis for determination of dextromethorphan metabolic phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

The misuse of urinary metabolite excretion data in drug metabolism studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990187-3

10.1016/S0009-9236(96)90187-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8646830%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference